Evidence map›Paper›PMID 23045271›Full record

ArticleOncogene2013

Distinct roles for fibroblast growth factor signaling in cerebellar development and medulloblastoma.

B A Emmenegger, E I Hwang, C Moore, S L Markant, S N Brun, J W Dutton, T-A Read, M P Fogarty, A R Singh, D L Durden and 3 more

Abstract read
In one paragraph

Article in Oncogene, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Targeting Angiogenic Factors for the Treatment of Medulloblastoma.Current treatment options in oncology · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 11 institutions in 1 country.

B A EmmeneggerDepartment of Pharmacology & Cancer Biology and Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.
E I Hwang
C Moore
S L Markant
S N Brun
J W Dutton
T-A Read
M P Fogarty
A R Singh
D L Durden
C Yang
W L McKeehan
R J Wechsler-Reya
Discovery Institute · USUniversity of California, San Diego · USChildren's National · USDuke Medical Center · USDuke University · USDuke University Hospital · USEmory University · USMitchell Institute · USNorth Carolina State University · USTexas A&M Health Science Center · USUniversity of North Carolina at Chapel Hill · US

Funding

Targeting Tumor Microenvironment-Induced Therapy Resistance in Prostate Cancer Bone MetastasisP50CA140388 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LOGOTHETIS, CHRISTOPHER J., THOMPSON, TIMOTHY CHARLES · 2009 to 2022
$23.4M
Control of Cerebellar Development by FGF signalingR01MH067916 · NIMH · DUKE UNIVERSITY · PI WECHSLER-REYA, ROBERT J. · 2004 to 2008
$1.6M
NCI NIH HHS P50 CA140388NIMH NIH HHS MH67916NIMH NIH HHS R01 MH067916
6 · The paper itself

Abstract

Cerebellar granule neurons are the most abundant neurons in the brain, and a critical element of the circuitry that controls motor coordination and learning. In addition, granule neuron precursors (GNPs) are thought to represent cells of origin for medulloblastoma, the most common malignant brain tumor in children. Thus, understanding the signals that control the growth and differentiation of these cells has important implications for neurobiology and neurooncology. Our previous studies have shown that proliferation of GNPs is regulated by Sonic hedgehog (Shh), and that aberrant activation of the Shh pathway can lead to medulloblastoma. Moreover, we have demonstrated that Shh-dependent proliferation of GNPs and medulloblastoma cells can be blocked by basic fibroblast growth factor (bFGF). But while the mitogenic effects of Shh signaling have been confirmed in vivo, the inhibitory effects of bFGF have primarily been studied in culture. Here, we demonstrate that mice lacking FGF signaling in GNPs exhibit no discernable changes in GNP proliferation or differentiation. In contrast, activation of FGF signaling has a potent effect on tumor growth: treatment of medulloblastoma cells with bFGF prevents them from forming tumors following transplantation, and inoculation of tumor-bearing mice with bFGF markedly inhibits tumor growth in vivo. These results suggest that activators of FGF signaling may be useful for targeting medulloblastoma and other Shh-dependent tumors.

Indexed as

AnimalsCell CycleCell DifferentiationCerebellar NeoplasmsCerebellumFibroblast Growth Factor 2Hedgehog ProteinsMedulloblastomaMiceMice, Inbred C57BLNeuronsReceptor, Fibroblast Growth Factor, Type 1Signal TransductionStem CellsFgfr1 protein, mouseFibroblast Growth Factor 2Hedgehog ProteinsReceptor, Fibroblast Growth Factor, Type 1Shh protein, mouse

Identifiers

PMID23045271
PMCPMC3808889
OpenAlexW2053068153

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.